Array

UNESP
AUIN | Agência Unesp de Inovação
   

Tecnology

NEW COMPOUNDS OF LOW TOXICITY AND HIGH SELECTIVITY FOR THE TREATMENT OF LEISHMANIASIS

Carimbo Unesp

Low Toxicity

Several

Effective treatment
Biotechnology
New Materials
Human Health
PROBLEM

The drugs currently available to combat leishmaniasis, a disease that affects populations in socioeconomically disadvantaged regions and that can lead to death, are ineffective, elicit severe and persistent side effects, and require long-term treatment. there is a demand for drugs that eliminate the parasite quickly and effectively without compromising the patient’s health.

SOLUTION

This newly developed product includes new derivatives that, in laboratory tests, showed higher indices of selectivity for leishmaniasis agents than the drugs currently in use, as well as low toxicity and safer and more effective treatments. in addition to leishmaniasis, the product has a potential for therapeutic use in combating other diseases, such as viral, cardiovascular, inflammatory, metabolic, bacterial, and fungal diseases, cancer and trypanosomiasis.


Idea

Laboratory

Prototype

Scheduling

Market
Agency Code
17AUIN016
Patent
BR 102018010542 6

Agência Unesp de Inovação

Tel: +55 11 5627.0696

auin@unesp.br

https://auin.unesp.br

Date of deposit
23/05/2018
Inventor(s)
Data in the Unesp repository
FAPESP
Facebook AUIN Unesp Youtube AUIN Unesp Instagram AUIN Unesp